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Introduction
Ventriculoperitoneal shunts (VPS) are a critical feature of
management of pediatric hydrocephalus. Unfortunately,
shunt failure is often unrecognized before significant symp-
toms and focal signs present, requiring costly emergency
room visits and neuroimaging. Ventricular CSF biomarkers
of neuropathology and neurodevelopment are emerging as
critical predictors of real-time physiology in pediatric
hydrocephalus. Moreover, in the future, biomarkers of neu-
ropathology could be pre-operatively analyzed from shunts
in question, reducing unnecessary surgical exploration. In
this pilot study, CSF samples taken during surgical explora-
tion were compared, hypothesizing that that two critical
CSF proteins, amyloid precursor protein (APP) and neural
cell adhesion molecule (NCAM-1), known to be elevated
in untreated hydrocephalus, may discriminate between
functioning and malfunctioning shunts.
Methods
Approval from the Washington University Human
Research Protection Office was acquired, and a pediatric
CSF repository was established. All patients prospectively
enrolled were between 0-4 years of age and were under-
going surgical exploration of proximal, valve, and distal
components of VPS for suspected CSF diversion failure.
CSF was acquired in the operating room under sterile con-
ditions, transported on ice, centrifuged, and supernatant
was stored at -80°C until experimental analysis. Enzyme-
linked immunosorbent assay (ELISA) was used to examine
CSF concentration of APP and NCAM-1. Total protein
was assessed using a standard Pierce Bicinchoninic Acid
(BCA) protein assay kit. A microplate reader was used to
assess biomarker concentration (ng/mL). Mann-Whitney U
analysis was used for comparison of these non-parametric
data, with statistical significance threshold set a priori at
p<0.05.
Results
Twenty eight patients were found to have malfunctioned
VPS, while 5 were found to have functioning VPS. There
were no significant differences in age at the time of ventri-
cle CSF sample (p=0.07), levels of total CSF protein
(p=0.335), total APP (p=0.516), or total NCAM (p=0.816)
concentrations. However, due to the fact that there is sig-
nificant inter-individual variation in CSF total protein
levels, we compared normalized APP (nAPP) and normal-
ized NCAM-1 (nNCAM) between the two groups.
Patients found to have nonfunctioning shunts had a
significantly elevated nAPP (p=0.044) and tended to
have elevated nNCAM (p=0.061) when compared to
patients with functioning shunts.
Conclusions
nAPP and nNCAM concentrations in ventricular CSF may
be elevated in malfunctioning VPS, when compared to
similarly aged patients with functioning shunts. While this
is a small pilot study, active enrollment continues of new
patients into this study given its potential implications.
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